tradingkey.logo
tradingkey.logo
Search

Enveric Biosciences Inc

ENVB
Add to Watchlist
1.580USD
+0.150+10.49%
Close 07-31 16:00ETQuotes delayed by 15 min
2.98MMarket Cap
LossP/E TTM

ENVB Financials

See Enveric Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Enveric Biosciences Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-1.08/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-36.24
84.14%
Analyst Rating
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
11.02%-1.08
-27.62%-6.12
-3512.49%-129.76
-213.47%-11.65
86.80%-1.22
78.73%-4.80
81.63%-3.59
91.84%-3.72
73.42%-9.21
64.37%-22.56
---19.56
---45.55
---34.65
---63.31
----
----
----
----
----
----
Net Profit
25.24%-1.63M
-28.07%-4.04M
-62.53%-3.39M
-34.04%-2.52M
11.07%-2.18M
8.19%-3.15M
26.16%-2.08M
70.63%-1.88M
48.82%-2.46M
60.96%-3.44M
-8.44%-2.82M
-122.81%-6.40M
-6.12%-4.80M
79.10%-8.80M
4.05%-2.60M
-216.23%-2.87M
-39.17%-4.52M
-860.77%-42.11M
-379.79%-2.71M
-10.98%-908.29K
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
Operating profit
25.34%-1.63M
30.87%-2.19M
10.04%-1.87M
-32.73%-2.52M
11.70%-2.19M
-33.11%-3.17M
39.59%-2.08M
67.02%-1.90M
49.03%-2.48M
50.35%-2.38M
39.04%-3.45M
-22.27%-5.76M
-1.35%-4.86M
60.96%-4.80M
-60.85%-5.66M
-39.96%-4.71M
29.11%-4.80M
-249.10%-12.30M
-617.97%-3.52M
-338.17%-3.36M
Net Profit
25.24%-1.63M
-28.07%-4.04M
-62.53%-3.39M
-34.04%-2.52M
11.07%-2.18M
8.19%-3.15M
26.16%-2.08M
70.63%-1.88M
48.82%-2.46M
60.96%-3.44M
-8.44%-2.82M
-122.81%-6.40M
-6.12%-4.80M
79.10%-8.80M
4.05%-2.60M
-216.23%-2.87M
-39.17%-4.52M
-860.77%-42.11M
-379.79%-2.71M
-10.98%-908.29K
Current assets
11.17%5.38M
80.53%4.94M
-3.98%4.17M
-40.08%3.31M
-41.25%4.83M
-23.65%2.73M
-25.55%4.34M
-37.98%5.52M
-44.55%8.23M
-80.57%3.58M
-73.83%5.83M
-54.05%8.90M
-34.53%14.84M
3.92%18.43M
-0.07%22.27M
-9.95%19.37M
-3.24%22.67M
678.21%17.74M
97.09%22.28M
109.45%21.51M
Total current liabilities
-61.10%460.68K
-38.35%918.40K
7.95%905.88K
111.31%1.36M
-49.98%1.18M
-36.43%1.49M
-79.94%839.17K
-86.90%645.34K
-46.65%2.37M
-41.35%2.34M
61.02%4.18M
111.89%4.93M
112.00%4.44M
91.79%4.00M
20.13%2.60M
99.11%2.32M
233.92%2.09M
205.84%2.08M
-84.54%2.16M
-90.86%1.17M
Total assets
8.22%5.52M
65.32%5.10M
-8.94%4.36M
-41.36%3.55M
-42.35%5.10M
-28.31%3.08M
-27.63%4.79M
-38.25%6.05M
-44.17%8.85M
-78.01%4.30M
-78.55%6.62M
-65.70%9.80M
-50.74%15.85M
-26.82%19.55M
-55.77%30.86M
20.58%28.57M
24.79%32.18M
552.18%26.72M
149.19%69.76M
-13.86%23.69M
Total liabilities
-61.10%460.68K
-38.35%918.40K
7.95%905.88K
111.31%1.36M
-49.98%1.18M
-36.43%1.49M
-79.94%839.17K
-86.90%645.34K
-46.65%2.37M
-41.35%2.34M
-42.33%4.18M
-17.47%4.93M
-42.64%4.44M
-9.45%4.00M
-49.60%7.25M
22.40%5.97M
13.87%7.74M
547.81%4.41M
-2.88%14.39M
-66.66%4.88M
Total equity
29.18%5.06M
162.28%4.18M
-12.53%3.46M
-59.59%2.18M
-39.56%3.92M
-18.58%1.59M
62.22%3.95M
10.91%5.41M
-43.21%6.48M
-87.42%1.96M
-89.68%2.44M
-78.43%4.87M
-53.30%11.41M
-30.26%15.56M
-57.37%23.60M
20.11%22.60M
28.70%24.44M
553.05%22.31M
320.22%55.37M
46.11%18.82M
Net operating income
5.63%-2.26M
-36.09%-1.78M
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.42%-2.60M
49.42%-1.75M
39.78%-2.74M
2.60%-4.47M
-12.93%-5.14M
14.88%-3.46M
-106.26%-4.55M
-126.78%-4.59M
-43.85%-4.55M
-13371.94%-4.07M
-460.32%-2.21M
-475.81%-2.02M
Net investment
----
----
----
----
----
----
----
-100.00%0.00
100.00%0.00
99.39%-38.00
100.11%20.00
131.27%16.85K
98.98%-5.17K
96.74%-6.19K
-100.61%-18.57K
---53.89K
25.11%-505.51K
-9619.22%-189.72K
--3.06M
--0.00
Net financing
-43.73%2.50M
480.25%2.69M
478.02%2.99M
1204.37%449.10K
-33.18%4.45M
349.05%463.45K
593.04%517.69K
103.27%34.43K
--6.66M
-18608300.00%-186.08K
-101.34%-105.00K
-209.81%-1.05M
-100.00%0.00
-114.29%-1.00
86935833.33%7.82M
5243.81%958.04K
-62.23%9.40M
100.00%7.00
-100.00%-9.00
-96.36%17.93K

FAQs

What are the current assets of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its current assets were 4.94M, with a year-on-year change of 80.53.

What are the total assets of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its total assets of Enveric Biosciences Inc were 5.10M, with a year-on-year change of 65.32.

What are the total liabilities of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its total liabilities of Enveric Biosciences Inc were 918.40K, with a year-on-year change of -38.35.

What is the total equity of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its total equity of Enveric Biosciences Inc was 4.18M, with a year-on-year change of 162.28.

What is the net operating income of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its net operating income of Enveric Biosciences Inc was -8.77M, with a year-on-year change of 8.91.

What is the net financing of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its net financing of Enveric Biosciences Inc was 10.58M, with a year-on-year change of 37.86.

What is the Earnings Per Share (EPS) of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -36.24, with a year-on-year change of 84.14.

What is the net income of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its net income was -12.13M, with a year-on-year change of -26.70.

What is the Return on Equity (ROE) of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -420.48, with a year-on-year change of 22.07.

What is the Return on Assets (ROA) of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -214.51, with a year-on-year change of 17.30.

What is the operating profit of Enveric Biosciences Inc?

According to Enveric Biosciences Inc's FY2025 earnings report, its operating profit was -8.77M, with a year-on-year change of 8.91.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.